id	sid	eid	entity	type
ajlm-1964	1	1	covid-19	DATE
ajlm-1964	1	2	covid-19	PRODUCT
ajlm-1964	1	3	african	NORP
ajlm-1964	1	4	africa	LOC
ajlm-1964	1	5	africa	LOC
ajlm-1964	1	6	covid-19	ORG
ajlm-1964	1	7	university of lagos	ORG
ajlm-1964	1	8	lagos	GPE
ajlm-1964	1	9	nigeria	GPE
ajlm-1964	1	10	yusuf o. omosun department	PERSON
ajlm-1964	1	11	morehouse school of medicine	ORG
ajlm-1964	1	12	atlanta	GPE
ajlm-1964	1	13	georgia	GPE
ajlm-1964	1	14	united states	GPE
ajlm-1964	1	15	joseph u. igietseme department	PERSON
ajlm-1964	1	16	morehouse school of medicine	ORG
ajlm-1964	1	17	atlanta	GPE
ajlm-1964	1	18	georgia	GPE
ajlm-1964	1	19	united states	GPE
ajlm-1964	1	20	cdc	ORG
ajlm-1964	1	21	atlanta	GPE
ajlm-1964	1	22	georgia	GPE
ajlm-1964	1	23	united states	GPE
ajlm-1964	1	24	anthony a. azenabor	PERSON
ajlm-1964	1	25	university of lagos	ORG
ajlm-1964	1	26	lagos	GPE
ajlm-1964	1	27	nigeria	GPE
ajlm-1964	1	28	omosun yo	PERSON
ajlm-1964	1	29	igietseme ju	PERSON
ajlm-1964	2	1	covid-19	PERSON
ajlm-1964	2	2	africa	LOC
ajlm-1964	3	1	afr j	PERSON
ajlm-1964	4	1	2023;12(1	CARDINAL
ajlm-1964	4	2	covid-19	PRODUCT
ajlm-1964	4	3	africa	LOC
ajlm-1964	4	4	yusuf o. omosun	PERSON
ajlm-1964	4	5	joseph u. igietseme	PERSON
ajlm-1964	4	6	anthony a. azenabor	PERSON
ajlm-1964	4	7	01 june 2022	DATE
ajlm-1964	4	8	24 oct. 2022	DATE
ajlm-1964	4	9	30	CARDINAL
ajlm-1964	5	1	2023	CARDINAL
ajlm-1964	5	2	2023	CARDINAL
ajlm-1964	9	1	2	CARDINAL
ajlm-1964	9	2	first	ORDINAL
ajlm-1964	9	3	china	GPE
ajlm-1964	9	4	2019	DATE
ajlm-1964	10	1	africa	LOC
ajlm-1964	11	1	2019	DATE
ajlm-1964	11	2	covid-19	ORG
ajlm-1964	11	3	africa	LOC
ajlm-1964	11	4	2020	DATE
ajlm-1964	11	5	covid-19	GPE
ajlm-1964	11	6	africa	LOC
ajlm-1964	11	7	covid-19	DATE
ajlm-1964	12	1	covid-19	PERSON
ajlm-1964	12	2	immunoglobin	GPE
ajlm-1964	12	3	immunoglobin	PERSON
ajlm-1964	14	1	covid-19	GPE
ajlm-1964	16	1	africa	LOC
ajlm-1964	16	2	africans	NORP
ajlm-1964	17	1	covid-19	PERSON
ajlm-1964	17	2	africa	LOC
ajlm-1964	18	1	december 2019	DATE
ajlm-1964	18	2	first	ORDINAL
ajlm-1964	18	3	wuhan	GPE
ajlm-1964	18	4	hubei	GPE
ajlm-1964	18	5	2019-ncov.1,2	CARDINAL
ajlm-1964	18	6	11 march 2020	DATE
ajlm-1964	18	7	the world health organization	ORG
ajlm-1964	18	8	2019	DATE
ajlm-1964	18	9	covid-19	ORG
ajlm-1964	18	10	2	CARDINAL
ajlm-1964	19	1	07 september 2021	DATE
ajlm-1964	19	2	4 566 167	CARDINAL
ajlm-1964	19	3	225	CARDINAL
ajlm-1964	19	4	2.1%.3	CARDINAL
ajlm-1964	19	5	covid-19	PRODUCT
ajlm-1964	19	6	2–14 days	DATE
ajlm-1964	19	7	six	CARDINAL
ajlm-1964	19	8	four	CARDINAL
ajlm-1964	19	9	nl63	PRODUCT
ajlm-1964	19	10	hku1	ORG
ajlm-1964	19	11	oc43	PRODUCT
ajlm-1964	19	12	first	ORDINAL
ajlm-1964	19	13	2002,15,16,17	CARDINAL
ajlm-1964	19	14	middle east	LOC
ajlm-1964	19	15	2012,18	CARDINAL
ajlm-1964	19	16	two	CARDINAL
ajlm-1964	20	1	middle east	LOC
ajlm-1964	20	2	8100	CARDINAL
ajlm-1964	20	3	2500	CARDINAL
ajlm-1964	21	1	2019	CARDINAL
ajlm-1964	21	2	african	NORP
ajlm-1964	21	3	covid-19	PERSON
ajlm-1964	21	4	million	CARDINAL
ajlm-1964	21	5	africa	LOC
ajlm-1964	21	6	13	CARDINAL
ajlm-1964	22	1	african	NORP
ajlm-1964	22	2	13	CARDINAL
ajlm-1964	22	3	africa	LOC
ajlm-1964	23	1	africa	LOC
ajlm-1964	24	1	africa	LOC
ajlm-1964	24	2	african	NORP
ajlm-1964	25	1	covid-19	ORG
ajlm-1964	25	2	african	NORP
ajlm-1964	26	1	1	CARDINAL
ajlm-1964	26	2	covid-19	ORG
ajlm-1964	26	3	million	CARDINAL
ajlm-1964	26	4	07 september 2021	DATE
ajlm-1964	27	1	1	CARDINAL
ajlm-1964	27	2	covid-19	ORG
ajlm-1964	27	3	african	NORP
ajlm-1964	27	4	between 05 february 2020	DATE
ajlm-1964	27	5	07 september 2021	DATE
ajlm-1964	28	1	covid-19	PERSON
ajlm-1964	28	2	africa	LOC
ajlm-1964	28	3	covid-19	ORG
ajlm-1964	28	4	african	NORP
ajlm-1964	28	5	pubmed	ORG
ajlm-1964	28	6	african	NORP
ajlm-1964	28	7	nigeria centre	LOC
ajlm-1964	28	8	africa centre	LOC
ajlm-1964	29	1	english	LANGUAGE
ajlm-1964	29	2	2021	CARDINAL
ajlm-1964	30	1	covid-19	ORG
ajlm-1964	33	1	immunoglobin	GPE
ajlm-1964	33	2	immunoglobin	PERSON
ajlm-1964	33	3	antibodies.22,23,24	NORP
ajlm-1964	35	1	cd4+/cd8	ORG
ajlm-1964	35	2	cases.10	PRODUCT
ajlm-1964	36	1	cd4+/cd8	ORG
ajlm-1964	36	2	african	NORP
ajlm-1964	37	1	between 10 and 21 days	DATE
ajlm-1964	37	2	between 6 and 15 days	DATE
ajlm-1964	37	3	immunoglobin	PERSON
ajlm-1964	37	4	up to 4 weeks	DATE
ajlm-1964	38	1	188	CARDINAL
ajlm-1964	38	2	covid-19	ORG
ajlm-1964	39	1	covid-19	ORG
ajlm-1964	39	2	covid-19	ORG
ajlm-1964	41	1	between 12 and 52 weeks	CARDINAL
ajlm-1964	41	2	reinfections.33	GPE
ajlm-1964	41	3	immunoglobin	PERSON
ajlm-1964	41	4	two years	DATE
ajlm-1964	41	5	90%	PERCENT
ajlm-1964	41	6	three years	DATE
ajlm-1964	41	7	50%	PERCENT
ajlm-1964	41	8	patients,34	DATE
ajlm-1964	41	9	day 49	DATE
ajlm-1964	41	10	at least 80%	PERCENT
ajlm-1964	41	11	cases.36	PRODUCT
ajlm-1964	41	12	95%	PERCENT
ajlm-1964	41	13	approximately six months	DATE
ajlm-1964	41	14	covid-19	PRODUCT
ajlm-1964	41	15	african	NORP
ajlm-1964	41	16	africa	LOC
ajlm-1964	42	1	07 september 2021	DATE
ajlm-1964	42	2	covid-19	ORG
ajlm-1964	42	3	55	CARDINAL
ajlm-1964	42	4	african	NORP
ajlm-1964	42	5	7 926 999	DATE
ajlm-1964	42	6	200 045	CARDINAL
ajlm-1964	42	7	3.6%	PERCENT
ajlm-1964	42	8	4.4%	PERCENT
ajlm-1964	43	1	africa	LOC
ajlm-1964	43	2	covid-19	ORG
ajlm-1964	43	3	23	CARDINAL
ajlm-1964	44	1	07 september 2021	DATE
ajlm-1964	44	2	south africa	GPE
ajlm-1964	44	3	africa	LOC
ajlm-1964	44	4	covid-19	ORG
ajlm-1964	44	5	2 819 945	QUANTITY
ajlm-1964	44	6	africa	LOC
ajlm-1964	44	7	ethiopia	GPE
ajlm-1964	44	8	314 984	CARDINAL
ajlm-1964	44	9	kenya	GPE
ajlm-1964	44	10	240 172	CARDINAL
ajlm-1964	44	11	zambia	GPE
ajlm-1964	44	12	207 114	CARDINAL
ajlm-1964	44	13	nigeria	GPE
ajlm-1964	44	14	195	CARDINAL
ajlm-1964	44	15	botswana	ORG
ajlm-1964	44	16	162 186).37	CARDINAL
ajlm-1964	44	17	nigeria	GPE
ajlm-1964	44	18	african	NORP
ajlm-1964	44	19	fifth	ORDINAL
ajlm-1964	44	20	africa	LOC
ajlm-1964	44	21	africa	LOC
ajlm-1964	45	1	africa	LOC
ajlm-1964	45	2	africa	LOC
ajlm-1964	45	3	africa	LOC
ajlm-1964	46	1	2	CARDINAL
ajlm-1964	46	2	covid-19	ORG
ajlm-1964	46	3	africa	LOC
ajlm-1964	46	4	05 february 2020	DATE
ajlm-1964	46	5	07 september 2021	DATE
ajlm-1964	47	1	age of under 20 years	DATE
ajlm-1964	47	2	africa	LOC
ajlm-1964	47	3	european union	ORG
ajlm-1964	47	4	43 years	DATE
ajlm-1964	47	5	china	GPE
ajlm-1964	47	6	the united states	GPE
ajlm-1964	47	7	38 years).39	DATE
ajlm-1964	47	8	only 3%	PERCENT
ajlm-1964	47	9	african	NORP
ajlm-1964	47	10	above 65 years	DATE
ajlm-1964	47	11	covid-19.40	PRODUCT
ajlm-1964	47	12	nigeria	GPE
ajlm-1964	47	13	africa	LOC
ajlm-1964	47	14	44%	PERCENT
ajlm-1964	47	15	the age of 15 years	DATE
ajlm-1964	47	16	africa	LOC
ajlm-1964	47	17	households41	ORG
ajlm-1964	48	1	covid-19	DATE
ajlm-1964	49	1	africa	LOC
ajlm-1964	49	2	69%	PERCENT
ajlm-1964	49	3	africa	LOC
ajlm-1964	49	4	lassa	PERSON
ajlm-1964	49	5	six	CARDINAL
ajlm-1964	49	6	2019	DATE
ajlm-1964	49	7	10	CARDINAL
ajlm-1964	49	8	years	DATE
ajlm-1964	50	1	mosquitoes.50	DATE
ajlm-1964	50	2	2020	DATE
ajlm-1964	50	3	3.2 billion	CARDINAL
ajlm-1964	50	4	96	CARDINAL
ajlm-1964	50	5	africa	LOC
ajlm-1964	51	1	94%	PERCENT
ajlm-1964	51	2	94%	PERCENT
ajlm-1964	51	3	67%	PERCENT
ajlm-1964	51	4	under five	DATE
ajlm-1964	52	1	death.51,52	DATE
ajlm-1964	52	2	37.7 million	CARDINAL
ajlm-1964	52	3	000	CARDINAL
ajlm-1964	52	4	africa	LOC
ajlm-1964	52	5	67%	PERCENT
ajlm-1964	52	6	39%	PERCENT
ajlm-1964	52	7	covid-19	ORG
ajlm-1964	52	8	covid-19	ORG
ajlm-1964	52	9	2019	DATE
ajlm-1964	52	10	10 million	CARDINAL
ajlm-1964	52	11	208 000	CARDINAL
ajlm-1964	52	12	over 1.2 million	CARDINAL
ajlm-1964	52	13	15%	PERCENT
ajlm-1964	52	14	hiv).56 africa	GPE
ajlm-1964	52	15	second	ORDINAL
ajlm-1964	52	16	25%	PERCENT
ajlm-1964	52	17	2019.56	CARDINAL
ajlm-1964	52	18	central african	NORP
ajlm-1964	52	19	guinea	GPE
ajlm-1964	52	20	west africa	GPE
ajlm-1964	52	21	2014	DATE
ajlm-1964	52	22	leone	PRODUCT
ajlm-1964	52	23	liberia	GPE
ajlm-1964	52	24	an estimated 11 000	QUANTITY
ajlm-1964	52	25	april 2016.61,62,63	DATE
ajlm-1964	52	26	3	CARDINAL
ajlm-1964	52	27	https://biorender.com/	PERSON
ajlm-1964	53	1	first	ORDINAL
ajlm-1964	53	2	controls.64	ORG
ajlm-1964	53	3	3	CARDINAL
ajlm-1964	54	1	first	ORDINAL
ajlm-1964	55	1	second	ORDINAL
ajlm-1964	59	1	first	ORDINAL
ajlm-1964	59	2	mediators.70,71,72	ORG
ajlm-1964	59	3	while.73	NORP
ajlm-1964	60	1	africa	LOC
ajlm-1964	60	2	covid-19	PRODUCT
ajlm-1964	60	3	more than 90%	PERCENT
ajlm-1964	60	4	at least three	CARDINAL
ajlm-1964	60	5	one	CARDINAL
ajlm-1964	60	6	20%	PERCENT
ajlm-1964	60	7	50%	PERCENT
ajlm-1964	60	8	germany	GPE
ajlm-1964	60	9	mortality.78,84	ORG
ajlm-1964	63	1	africa	LOC
ajlm-1964	63	2	europe	LOC
ajlm-1964	63	3	north america	LOC
ajlm-1964	64	1	two	CARDINAL
ajlm-1964	64	2	african	NORP
ajlm-1964	64	3	gabon	GPE
ajlm-1964	64	4	senegal	GPE
ajlm-1964	64	5	europe	LOC
ajlm-1964	64	6	gabon	GPE
ajlm-1964	64	7	central africa	GPE
ajlm-1964	64	8	nigeria	GPE
ajlm-1964	64	9	ghana	GPE
ajlm-1964	64	10	benin	GPE
ajlm-1964	64	11	west africa	GPE
ajlm-1964	64	12	tanzania	GPE
ajlm-1964	64	13	east africa	GPE
ajlm-1964	64	14	zambia	GPE
ajlm-1964	64	15	africa	LOC
ajlm-1964	64	16	s proteins,87,88,89,90	ORG
ajlm-1964	64	17	africa	LOC
ajlm-1964	65	1	france	GPE
ajlm-1964	65	2	england	GPE
ajlm-1964	65	3	the united states	GPE
ajlm-1964	65	4	african	NORP
ajlm-1964	65	5	africa	LOC
ajlm-1964	65	6	europe	LOC
ajlm-1964	65	7	south africa	GPE
ajlm-1964	65	8	african	NORP
ajlm-1964	67	1	africa	LOC
ajlm-1964	67	2	african	NORP
ajlm-1964	69	1	covid-19	GPE
ajlm-1964	70	1	m. tuberculosis.95,96	PERSON
ajlm-1964	70	2	infection97	GPE
ajlm-1964	72	1	m. tuberculosis	PERSON
ajlm-1964	73	1	diseases.99	GPE
ajlm-1964	73	2	65 years	DATE
ajlm-1964	73	3	immunity.97	ORG
ajlm-1964	74	1	bcg	ORG
ajlm-1964	74	2	up to 30–40 years	DATE
ajlm-1964	74	3	up to 50–60 years	DATE
ajlm-1964	74	4	american	NORP
ajlm-1964	74	5	indians	NORP
ajlm-1964	74	6	alaska	GPE
ajlm-1964	74	7	covid-19	GPE
ajlm-1964	75	1	2020	DATE
ajlm-1964	75	2	covid-19	ORG
ajlm-1964	76	1	one	CARDINAL
ajlm-1964	76	2	2020	DATE
ajlm-1964	76	3	atlas	WORK_OF_ART
ajlm-1964	76	4	african	NORP
ajlm-1964	76	5	south sudan	LOC
ajlm-1964	77	1	african	NORP
ajlm-1964	79	1	covid-19	PERSON
ajlm-1964	80	1	africa	LOC
ajlm-1964	80	2	covid-19	PRODUCT
ajlm-1964	83	1	covid-19	ORG
ajlm-1964	83	2	five	CARDINAL
ajlm-1964	83	3	b.1.1.7	NORP
ajlm-1964	83	4	first	ORDINAL
ajlm-1964	83	5	the united kingdom	GPE
ajlm-1964	83	6	b.1.351	ORG
ajlm-1964	83	7	first	ORDINAL
ajlm-1964	83	8	south africa	GPE
ajlm-1964	83	9	brazil	GPE
ajlm-1964	83	10	first	ORDINAL
ajlm-1964	83	11	india	GPE
ajlm-1964	83	12	first	ORDINAL
ajlm-1964	83	13	south africa	GPE
ajlm-1964	85	1	e484k	GPE
ajlm-1964	85	2	thousands	CARDINAL
ajlm-1964	86	1	3–6	CARDINAL
ajlm-1964	86	2	77	CARDINAL
ajlm-1964	86	3	december 2021.119,120	DATE
ajlm-1964	86	4	omicron	ORG
ajlm-1964	88	1	african	NORP
ajlm-1964	89	1	africa	LOC
ajlm-1964	90	1	2014	DATE
ajlm-1964	90	2	african	NORP
ajlm-1964	92	1	africa	LOC
ajlm-1964	93	1	africa	LOC
ajlm-1964	94	1	african	NORP
ajlm-1964	95	1	africa	LOC
ajlm-1964	95	2	african	NORP
ajlm-1964	106	1	china	GPE
ajlm-1964	107	1	2020	DATE
ajlm-1964	108	1	2021	CARDINAL
ajlm-1964	108	2	sept 21	DATE
ajlm-1964	109	1	ae	ORG
ajlm-1964	109	2	baker sc	PERSON
ajlm-1964	110	1	2019	CARDINAL
ajlm-1964	111	1	nat	ORG
ajlm-1964	112	1	2020;5(4):536–544	ORG
ajlm-1964	114	1	covid-19	ORG
ajlm-1964	116	1	2020	DATE
ajlm-1964	117	1	2021	CARDINAL
ajlm-1964	117	2	sept 21	DATE
ajlm-1964	118	1	chen n	PERSON
ajlm-1964	118	2	zhou m	PERSON
ajlm-1964	118	3	dong x	PERSON
ajlm-1964	118	4	99	CARDINAL
ajlm-1964	118	5	2019	CARDINAL
ajlm-1964	118	6	wuhan	GPE
ajlm-1964	118	7	china	GPE
ajlm-1964	119	1	lancet	ORG
ajlm-1964	121	1	https://doi.org/10.1016/s0140-6736(20)30211-7 huang c	PERSON
ajlm-1964	121	2	wang y	PERSON
ajlm-1964	121	3	li x	PERSON
ajlm-1964	122	1	2019	CARDINAL
ajlm-1964	122	2	wuhan	GPE
ajlm-1964	122	3	china	GPE
ajlm-1964	123	1	lancet	ORG
ajlm-1964	125	1	https://doi.org/10.1016/s0140-6736(20)30183-5 hu	PERSON
ajlm-1964	126	1	guo h	ORG
ajlm-1964	127	1	zhou p	PERSON
ajlm-1964	127	2	shi z-l.	PERSON
ajlm-1964	127	3	covid-19	PERSON
ajlm-1964	128	1	nat rev microbiol	PERSON
ajlm-1964	130	1	chan jf-w	PERSON
ajlm-1964	130	2	yuan s	GPE
ajlm-1964	130	3	kok k-h	PERSON
ajlm-1964	131	1	2019	CARDINAL
ajlm-1964	132	1	lancet	ORG
ajlm-1964	133	1	2020;395(10223):514–523	DATE
ajlm-1964	134	1	nishiura h	ORG
ajlm-1964	134	2	kobayashi t	ORG
ajlm-1964	135	1	covid-19	PERSON
ajlm-1964	136	1	2020;94:154–155	CARDINAL
ajlm-1964	137	1	mizumoto k	PERSON
ajlm-1964	137	2	kagaya k	PERSON
ajlm-1964	137	3	chowell g.	PERSON
ajlm-1964	137	4	2019	DATE
ajlm-1964	137	5	covid-19	ORG
ajlm-1964	137	6	yokohama	GPE
ajlm-1964	137	7	japan	GPE
ajlm-1964	137	8	2020	DATE
ajlm-1964	138	1	euro	CARDINAL
ajlm-1964	138	2	surveill bull eur sur mal transm	ORG
ajlm-1964	138	3	eur commun dis bull	ORG
ajlm-1964	139	1	2020;25(10):2000180	ORG
ajlm-1964	140	1	wang f	PERSON
ajlm-1964	140	2	nie j	ORG
ajlm-1964	140	3	wang h	PERSON
ajlm-1964	141	1	covid-19	GPE
ajlm-1964	143	1	2020;221(11):1762–1769	CARDINAL
ajlm-1964	144	1	bai y, yao l	PERSON
ajlm-1964	144	2	wei t	PERSON
ajlm-1964	144	3	covid-19	DATE
ajlm-1964	145	1	2020;323(14):1406–1407	CARDINAL
ajlm-1964	146	1	weiss sr	PERSON
ajlm-1964	146	2	leibowitz	ORG
ajlm-1964	147	1	2011	DATE
ajlm-1964	147	2	81:85–164	CARDINAL
ajlm-1964	148	1	knipe dm	PERSON
ajlm-1964	148	2	howley	ORG
ajlm-1964	149	1	david m. knipe	PERSON
ajlm-1964	149	2	peter m. howley	PERSON
ajlm-1964	150	1	philadelphia	GPE
ajlm-1964	150	2	wolters kluwer	ORG
ajlm-1964	150	3	lippincott williams & wilkins	ORG
ajlm-1964	150	4	2013	DATE
ajlm-1964	151	1	su s	PERSON
ajlm-1964	151	2	wong g	PERSON
ajlm-1964	151	3	shi w	PERSON
ajlm-1964	154	1	2016;24(6):490–502	CARDINAL
ajlm-1964	155	1	zhong ns	PERSON
ajlm-1964	155	2	zheng	PERSON
ajlm-1964	155	3	li ym	PERSON
ajlm-1964	155	4	guangdong	GPE
ajlm-1964	155	5	china	GPE
ajlm-1964	155	6	february, 2003	DATE
ajlm-1964	156	1	lancet	ORG
ajlm-1964	157	1	2003;362(9393):1353–1358	CARDINAL
ajlm-1964	158	1	https://doi.org/10.1016/s0140-6736(03)14630-2 ksiazek tg	PERSON
ajlm-1964	158	2	erdman d	GPE
ajlm-1964	160	1	2003;348(20):1953–1366	CARDINAL
ajlm-1964	161	1	preiser w	PERSON
ajlm-1964	163	1	2003;348(20):1967–1976	CARDINAL
ajlm-1964	164	1	https://doi.org/10.1056/nejmoa030747 zaki am	PERSON
ajlm-1964	164	2	van boheemen s	PERSON
ajlm-1964	165	1	saudi arabia	GPE
ajlm-1964	166	1	2012;367(19):1814–1820	CARDINAL
ajlm-1964	167	1	https://doi.org/10.1056/nejmoa1211721 cui j	PERSON
ajlm-1964	167	2	li f	PERSON
ajlm-1964	167	3	shi z-l.	PERSON
ajlm-1964	168	1	nat rev microbiol	PERSON
ajlm-1964	169	1	2019;17(3):181–192	CARDINAL
ajlm-1964	170	1	https://doi.org/10.1038/s41579-018-0118-9 wong g	PERSON
ajlm-1964	170	2	liu w	PERSON
ajlm-1964	170	3	liu y	PERSON
ajlm-1964	170	4	zhou	PERSON
ajlm-1964	170	5	bi y	PERSON
ajlm-1964	170	6	gao	PERSON
ajlm-1964	172	1	2015;18(4):398–401	CARDINAL
ajlm-1964	172	2	dan jm	PERSON
ajlm-1964	172	3	mateus j	PERSON
ajlm-1964	172	4	kato y	PERSON
ajlm-1964	173	1	up to 8 months	DATE
ajlm-1964	175	1	2021;371(6529	DATE
ajlm-1964	175	2	eabf4063	PERSON
ajlm-1964	176	1	https://doi.org/10.1126/science.abf4063	PERSON
ajlm-1964	176	2	ramirez si	PERSON
ajlm-1964	176	3	covid-19	PERSON
ajlm-1964	180	1	schmitz ks	PERSON
ajlm-1964	180	2	raadsen mp	PERSON
ajlm-1964	180	3	covid-19	GPE
ajlm-1964	181	1	sci immunol	ORG
ajlm-1964	182	1	2020;5(48	CARDINAL
ajlm-1964	183	1	eabd2071	LOC
ajlm-1964	185	1	covid-19	PERSON
ajlm-1964	187	1	https://doi.org/10.1038/s41586-020-2598-9 liu w	PERSON
ajlm-1964	187	2	liu l	PERSON
ajlm-1964	188	1	j clin microbiol	PERSON
ajlm-1964	189	1	2020;58(6	CARDINAL
ajlm-1964	190	1	https://doi.org/10.1128/jcm.00461-20 zhao j	PERSON
ajlm-1964	190	2	wang h	PERSON
ajlm-1964	191	1	2019	DATE
ajlm-1964	192	1	clin infect dis.	ORG
ajlm-1964	194	1	https://doi.org/10.1101/2020.03.02.20030189	GPE
ajlm-1964	194	2	nma	ORG
ajlm-1964	194	3	müller ma	PERSON
ajlm-1964	194	4	li w	PERSON
ajlm-1964	195	1	2	CARDINAL
ajlm-1964	197	1	2020;26(7):1478–1488	CARDINAL
ajlm-1964	198	1	liu b-z	PERSON
ajlm-1964	198	2	deng h-j	PERSON
ajlm-1964	198	3	covid-19	GPE
ajlm-1964	199	1	nat med.	PERSON
ajlm-1964	200	1	2020;26(6):845–848	CARDINAL
ajlm-1964	201	1	guggemos w	PERSON
ajlm-1964	204	1	ahmed r.	PERSON
ajlm-1964	205	1	sci u s a. 2017;114(16):4031–4033	ORG
ajlm-1964	206	1	https://doi.org/10.1073/pnas.1704507114 plotkin s	ORG
ajlm-1964	206	2	edwards km	PERSON
ajlm-1964	207	1	plotkin	PERSON
ajlm-1964	208	1	7th	ORDINAL
ajlm-1964	210	1	2017	CARDINAL
ajlm-1964	211	1	2021	CARDINAL
ajlm-1964	211	2	sept 22	DATE
ajlm-1964	212	1	piot p	PERSON
ajlm-1964	212	2	larson hj	PERSON
ajlm-1964	216	1	https://doi.org/10.1038/s41586-019-1656-7 kellam p	ORG
ajlm-1964	216	2	barclay w.	PERSON
ajlm-1964	218	1	2020;101(8):791–797	ORG
ajlm-1964	218	2	wu l-p	PERSON
ajlm-1964	218	3	wang n-c	PERSON
ajlm-1964	218	4	chang y-h	PERSON
ajlm-1964	222	1	gao	PERSON
ajlm-1964	222	2	zhang s.	PERSON
ajlm-1964	222	3	first	ORDINAL
ajlm-1964	224	1	2020;81(1):147–178	CARDINAL
ajlm-1964	225	1	xu	PERSON
ajlm-1964	226	1	covid-19	PERSON
ajlm-1964	228	1	2020;323(18):1848–1849	CARDINAL
ajlm-1964	229	1	africa cdc	GPE
ajlm-1964	229	2	86	CARDINAL
ajlm-1964	229	3	2019	DATE
ajlm-1964	229	4	covid-19	ORG
ajlm-1964	230	1	africa cdc	GPE
ajlm-1964	230	2	2021	CARDINAL
ajlm-1964	230	3	2022	CARDINAL
ajlm-1964	230	4	sept 27	DATE
ajlm-1964	231	1	caldwell hat	PERSON
ajlm-1964	232	1	covid-19	ORG
ajlm-1964	233	1	bmc public health	ORG
ajlm-1964	234	1	2022;22(1):750	TIME
ajlm-1964	235	1	kaseje n.	PERSON
ajlm-1964	235	2	africa	LOC
ajlm-1964	235	3	covid-19	PERSON
ajlm-1964	237	1	2020	DATE
ajlm-1964	238	1	2021	CARDINAL
ajlm-1964	239	1	cdc	ORG
ajlm-1964	240	1	covid-19	PERSON
ajlm-1964	242	1	2020	DATE
ajlm-1964	242	2	2021	CARDINAL
ajlm-1964	243	1	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html kaneda	PERSON
ajlm-1964	243	2	t	GPE
ajlm-1964	243	3	ashford	GPE
ajlm-1964	244	1	africa	LOC
ajlm-1964	244	2	covid-19	PRODUCT
ajlm-1964	245	1	2020	DATE
ajlm-1964	246	1	2020	DATE
ajlm-1964	246	2	aug 14	DATE
ajlm-1964	247	1	gona cm	PERSON
ajlm-1964	247	2	africa	LOC
ajlm-1964	247	3	1990–2017	CARDINAL
ajlm-1964	248	1	bmc public health	ORG
ajlm-1964	250	1	harries	DATE
ajlm-1964	250	2	maher d	ORG
ajlm-1964	250	3	hosseini sm	PERSON
ajlm-1964	250	4	nkhoma w	PERSON
ajlm-1964	252	1	africa	LOC
ajlm-1964	255	1	washington	GPE
ajlm-1964	255	2	dc	GPE
ajlm-1964	255	3	world bank	ORG
ajlm-1964	255	4	2006	DATE
ajlm-1964	255	5	2021	CARDINAL
ajlm-1964	255	6	nov 23	DATE
ajlm-1964	256	1	critchley ja	PERSON
ajlm-1964	256	2	johnstone lk	PERSON
ajlm-1964	256	3	unwin nc	PERSON
ajlm-1964	257	1	africa	LOC
ajlm-1964	260	1	2009;5:9	CARDINAL
ajlm-1964	260	2	https://doi.org/10.1186/1744-8603-5-9 corburn j	ORG
ajlm-1964	260	3	nairobi	GPE
ajlm-1964	260	4	kenya	GPE
ajlm-1964	261	1	j environ public health	PERSON
ajlm-1964	262	1	united nations	ORG
ajlm-1964	262	2	un	ORG
ajlm-1964	263	1	covid-19	PERSON
ajlm-1964	263	2	african	NORP
ajlm-1964	263	3	2020	DATE
ajlm-1964	267	1	2021	CARDINAL
ajlm-1964	268	1	2021	CARDINAL
ajlm-1964	268	2	nov 23	DATE
ajlm-1964	269	1	africa	LOC
ajlm-1964	270	1	watson rr	PERSON
ajlm-1964	272	1	new york	GPE
ajlm-1964	272	2	ny	GPE
ajlm-1964	272	3	2010	DATE
ajlm-1964	273	1	1171–1188	CARDINAL
ajlm-1964	274	1	world health organization	ORG
ajlm-1964	276	1	2020	DATE
ajlm-1964	277	1	2022	CARDINAL
ajlm-1964	277	2	oct 31	DATE
ajlm-1964	279	1	world malaria	EVENT
ajlm-1964	279	2	2020	DATE
ajlm-1964	281	1	2020	DATE
ajlm-1964	282	1	2021	CARDINAL
ajlm-1964	282	2	sept 23	DATE
ajlm-1964	283	1	watkins di.	PERSON
ajlm-1964	284	1	first	ORDINAL
ajlm-1964	285	1	nat immunol	PERSON
ajlm-1964	286	1	2005;6(5):430–432	CARDINAL
ajlm-1964	290	1	global hiv & aids	ORG
ajlm-1964	292	1	2020	DATE
ajlm-1964	293	1	2021	CARDINAL
ajlm-1964	293	2	sept 23	DATE
ajlm-1964	296	1	2018	DATE
ajlm-1964	297	1	2021 nov 07	DATE
ajlm-1964	298	1	toth	PERSON
ajlm-1964	301	1	world health organization	ORG
ajlm-1964	302	1	2020	DATE
ajlm-1964	303	1	2020	DATE
ajlm-1964	304	1	2021	CARDINAL
ajlm-1964	304	2	sept 23	DATE
ajlm-1964	305	1	: https://www.who.int/publications/i/item/9789240013131 world health organization	ORG
ajlm-1964	307	1	2021	CARDINAL
ajlm-1964	308	1	2021	CARDINAL
ajlm-1964	308	2	sept 23	DATE
ajlm-1964	309	1	johnson km	PERSON
ajlm-1964	309	2	morens dm	GPE
ajlm-1964	311	1	ann rev	PERSON
ajlm-1964	312	1	2017;12:387–418	CARDINAL
ajlm-1964	314	1	zaire	GPE
ajlm-1964	314	2	1976	DATE
ajlm-1964	315	1	bull world health organ	ORG
ajlm-1964	316	1	1978;56(2):271–293	CARDINAL
ajlm-1964	316	2	bermejo m	ORG
ajlm-1964	317	1	gabon	GPE
ajlm-1964	317	2	republic of congo	ORG
ajlm-1964	317	3	2001–2003	DATE
ajlm-1964	318	1	2005;11(2):283–290	TIME
ajlm-1964	318	2	cdc	ORG
ajlm-1964	319	1	2014–2016	CARDINAL
ajlm-1964	319	2	west africa	GPE
ajlm-1964	322	1	cdc	ORG
ajlm-1964	324	1	2016	DATE
ajlm-1964	325	1	2021	CARDINAL
ajlm-1964	325	2	sept 23	DATE
ajlm-1964	326	1	cem	ORG
ajlm-1964	326	2	johnson am	PERSON
ajlm-1964	326	3	heymann dl	PERSON
ajlm-1964	327	1	2013–2016	CARDINAL
ajlm-1964	328	1	philos trans	ORG
ajlm-1964	328	2	biol sci	PERSON
ajlm-1964	328	3	2017;372(1721):20160297	CARDINAL
ajlm-1964	329	1	horby p	ORG
ajlm-1964	329	2	west africa	GPE
ajlm-1964	330	1	lancet	ORG
ajlm-1964	332	1	iwasaki	PERSON
ajlm-1964	332	2	r. control	PERSON
ajlm-1964	333	1	nat immunol.	PERSON
ajlm-1964	334	1	2015;16(4):343–353	CARDINAL
ajlm-1964	336	1	adv immunol	PERSON
ajlm-1964	337	1	dianzani f	PERSON
ajlm-1964	337	2	s. nonspecific	PERSON
ajlm-1964	341	1	4th	ORDINAL
ajlm-1964	342	1	galveston	GPE
ajlm-1964	342	2	tx: university of texas medical	ORG
ajlm-1964	342	3	galveston	GPE
ajlm-1964	342	4	1996	DATE
ajlm-1964	342	5	2021 nov 21	DATE
ajlm-1964	347	1	4th	ORDINAL
ajlm-1964	348	1	galveston	GPE
ajlm-1964	348	2	tx: university of texas medical	ORG
ajlm-1964	348	3	galveston	GPE
ajlm-1964	348	4	1996	DATE
ajlm-1964	348	5	2021 nov 21	DATE
ajlm-1964	349	1	domínguez-andrés j	ORG
ajlm-1964	351	1	nat rev immunol	PERSON
ajlm-1964	352	1	2020;20(6):375–388	CARDINAL
ajlm-1964	353	1	quintin j	PERSON
ajlm-1964	353	2	van der meer jwm	PERSON
ajlm-1964	356	1	divangahi m	GPE
ajlm-1964	356	2	aaby p	PERSON
ajlm-1964	356	3	khader sa	PERSON
ajlm-1964	357	1	nat immunol	PERSON
ajlm-1964	358	1	2021;22(1):2–6	CARDINAL
ajlm-1964	359	1	parker d.	PERSON
ajlm-1964	361	1	2020;22(12	CARDINAL
ajlm-1964	361	2	dc	GPE
ajlm-1964	361	3	quintin j	PERSON
ajlm-1964	363	1	clin vaccine immunol	ORG
ajlm-1964	364	1	2014;21(4):534–545	CARDINAL
ajlm-1964	365	1	https://doi.org/10.1128/cvi.00688-13 kleinnijenhuis j	PERSON
ajlm-1964	365	2	quintin j	PERSON
ajlm-1964	365	3	bacille calmette-guerin	PERSON
ajlm-1964	365	4	nod2	ORG
ajlm-1964	366	1	sci u s a. 2012;109(43):17537–17542	ORG
ajlm-1964	367	1	lerm m	ORG
ajlm-1964	370	1	https://doi.org/10.1111/joim.12449	NORP
ajlm-1964	370	2	sancho	GPE
ajlm-1964	373	1	2018;9:2936	CARDINAL
ajlm-1964	378	1	https://doi.org/10.3389/fimmu.2018.00298 yuki k	PERSON
ajlm-1964	378	2	s. covid-19	PERSON
ajlm-1964	379	1	clin immunol	PERSON
ajlm-1964	380	1	2020;215:108427	CARDINAL
ajlm-1964	381	1	chakrabarti	NORP
ajlm-1964	381	2	kaur u	PERSON
ajlm-1964	381	3	singh	GPE
ajlm-1964	381	4	covid-19	GPE
ajlm-1964	381	5	india	GPE
ajlm-1964	383	1	2020;11(6):1339	CARDINAL
ajlm-1964	384	1	gorse gj	PERSON
ajlm-1964	384	2	patel	PERSON
ajlm-1964	384	3	vitale jn	PERSON
ajlm-1964	385	1	four	CARDINAL
ajlm-1964	386	1	clin vaccine immunol	PERSON
ajlm-1964	388	1	crotty s. cross-reactive	PERSON
ajlm-1964	389	1	nat rev immunol	PERSON
ajlm-1964	390	1	kunasegaran k	PERSON
ajlm-1964	391	1	covid-19	PERSON
ajlm-1964	393	1	2020;584(7821):457–462	CARDINAL
ajlm-1964	394	1	kream rm	ORG
ajlm-1964	395	1	j exp clin res	PERSON
ajlm-1964	396	1	2020;26	TIME
ajlm-1964	397	1	https://doi.org/10.12659/msm.929789 woldemeskel ba	PERSON
ajlm-1964	397	2	kwaa ak	PERSON
ajlm-1964	397	3	garliss cc	PERSON
ajlm-1964	397	4	o	DATE
ajlm-1964	397	5	ray sc	PERSON
ajlm-1964	398	1	j clin	PERSON
ajlm-1964	399	1	2020;130(12):6631–6638	CARDINAL
ajlm-1964	400	1	https://doi.org/10.12659/msm.929789 chakrabarti s	PERSON
ajlm-1964	400	2	chakrabarti ss	PERSON
ajlm-1964	400	3	kaur u	PERSON
ajlm-1964	400	4	agrawal bk	PERSON
ajlm-1964	400	5	ganguly u	PERSON
ajlm-1964	400	6	jin k. cross	PERSON
ajlm-1964	400	7	covid-19	DATE
ajlm-1964	402	1	2021;93(7):4094–4096	CARDINAL
ajlm-1964	403	1	zhao j	PERSON
ajlm-1964	403	2	mangalam ak	ORG
ajlm-1964	405	1	2016;44(6):1379–1391	CARDINAL
ajlm-1964	406	1	babuadze g	PERSON
ajlm-1964	407	1	west africa	GPE
ajlm-1964	407	2	covid-19	PRODUCT
ajlm-1964	408	1	sci rep.;12(1):12962	PERSON
ajlm-1964	409	1	tso	PERSON
ajlm-1964	410	1	africa	LOC
ajlm-1964	411	1	2021;102:577–583	CARDINAL
ajlm-1964	412	1	emmerich p	ORG
ajlm-1964	412	2	igg	ORG
ajlm-1964	412	3	african	NORP
ajlm-1964	414	1	2021;26(6):621–631	CARDINAL
ajlm-1964	415	1	mveang nzoghe	PERSON
ajlm-1964	417	1	immun inflamm	PERSON
ajlm-1964	418	1	2021;9(1):128–133	CARDINAL
ajlm-1964	419	1	sander al	PERSON
ajlm-1964	419	2	moreira-soto	PERSON
ajlm-1964	419	3	benin	GPE
ajlm-1964	421	1	2021;27(1	PERSON
ajlm-1964	422	1	https://doi.org/10.3201/eid2701.203281 grzelak l	ORG
ajlm-1964	423	1	four	CARDINAL
ajlm-1964	424	1	sci transl med.	ORG
ajlm-1964	425	1	eabc3103	PERSON
ajlm-1964	426	1	ng kw	PERSON
ajlm-1964	426	2	faulkner n	PERSON
ajlm-1964	426	3	cornish gh	PERSON
ajlm-1964	430	1	callaghan s	ORG
ajlm-1964	432	1	nat commun	PERSON
ajlm-1964	433	1	2021;12(1):2938	CARDINAL
ajlm-1964	437	1	2016;352(6284	DATE
ajlm-1964	438	1	wout jw	PERSON
ajlm-1964	438	2	poell r	ORG
ajlm-1964	438	3	van furth r.	PERSON
ajlm-1964	439	1	scand j immunol	PERSON
ajlm-1964	440	1	1992;36(5):713–719	CARDINAL
ajlm-1964	441	1	kaufmann e	PERSON
ajlm-1964	441	2	sanz j	PERSON
ajlm-1964	441	3	dunn jl	PERSON
ajlm-1964	444	1	2018;172(1–2):176–190.e19	CARDINAL
ajlm-1964	445	1	moorlag	PRODUCT
ajlm-1964	445	2	novakovic b	PERSON
ajlm-1964	449	1	de bree	PERSON
ajlm-1964	451	1	nat commun	PERSON
ajlm-1964	453	1	villarreal-ramos	ORG
ajlm-1964	453	2	mcshane h.	PERSON
ajlm-1964	456	1	moorlag	PRODUCT
ajlm-1964	458	1	clin	PERSON
ajlm-1964	460	1	linehan m	PERSON
ajlm-1964	460	2	a. bcg	PERSON
ajlm-1964	461	1	j allergy clin immunol	PERSON
ajlm-1964	462	1	2011;127(1):246–53	CARDINAL
ajlm-1964	462	2	253.e1	CARDINAL
ajlm-1964	463	1	nakayama k	PERSON
ajlm-1964	463	2	monma m	ORG
ajlm-1964	463	3	fukushima	GPE
ajlm-1964	463	4	sasaki h.	PERSON
ajlm-1964	466	1	nakayama k	PERSON
ajlm-1964	466	2	fukushima	GPE
ajlm-1964	466	3	chiba h	ORG
ajlm-1964	466	4	sasaki h.	PERSON
ajlm-1964	468	1	nihon ronen igakkai	ORG
ajlm-1964	468	2	zasshi jpn j	PERSON
ajlm-1964	469	1	2005;42(1):34–36	CARDINAL
ajlm-1964	469	2	moorlag	PERSON
ajlm-1964	471	1	2020;183(2):315–323.e9	CARDINAL
ajlm-1964	472	1	heldal e	PERSON
ajlm-1964	472	2	rodrigues lc	PERSON
ajlm-1964	472	3	abubakar	PERSON
ajlm-1964	472	4	norway	GPE
ajlm-1964	473	1	lancet	ORG
ajlm-1964	474	1	2016;16(2):219–226	CARDINAL
ajlm-1964	475	1	https://doi.org/10.1016/s1473-3099(15)00400-4 aronson ne	ORG
ajlm-1964	475	2	comstock gw	PERSON
ajlm-1964	476	1	american	NORP
ajlm-1964	476	2	indians	NORP
ajlm-1964	476	3	alaska	GPE
ajlm-1964	476	4	60-year	DATE
ajlm-1964	478	1	2004;291(17):2086–2091	CARDINAL
ajlm-1964	479	1	menzies d. interpretation	PERSON
ajlm-1964	481	1	j respir crit	PERSON
ajlm-1964	482	1	1999;159(1):15–21	CARDINAL
ajlm-1964	483	1	reandelar mj	PERSON
ajlm-1964	483	2	li y	PERSON
ajlm-1964	484	1	covid-19	PERSON
ajlm-1964	485	1	2020	DATE
ajlm-1964	486	1	2021 nov 16]:20042937	DATE
ajlm-1964	487	1	levine di	PERSON
ajlm-1964	488	1	covid-19	PERSON
ajlm-1964	488	2	spain	GPE
ajlm-1964	488	3	italy	GPE
ajlm-1964	489	1	2020	DATE
ajlm-1964	490	1	2021 nov 17]:20123539	DATE
ajlm-1964	491	1	curtis n	PERSON
ajlm-1964	492	1	covid-19	DATE
ajlm-1964	492	2	lancet	ORG
ajlm-1964	493	1	2020;395(10236):1545–1546	CARDINAL
ajlm-1964	494	1	brooks na	PERSON
ajlm-1964	494	2	puri	GPE
ajlm-1964	494	3	garg s	ORG
ajlm-1964	495	1	disease-19	DATE
ajlm-1964	495	2	bacille calmette-guerin	PERSON
ajlm-1964	496	1	sci rep	ORG
ajlm-1964	496	2	2021;11(1):774	CARDINAL
ajlm-1964	497	1	mcandrews km	PERSON
ajlm-1964	497	2	kalluri r. protection	PERSON
ajlm-1964	498	1	sci rep	ORG
ajlm-1964	498	2	2020;10(1):18377.	CARDINAL
ajlm-1964	499	1	seeley jj	PERSON
ajlm-1964	499	2	ghosh s.	PERSON
ajlm-1964	499	3	lps	ORG
ajlm-1964	500	1	j leukoc biol	PERSON
ajlm-1964	501	1	2017;101(1):107–119	CARDINAL
ajlm-1964	501	2	https://doi.org/10.1189/jlb.3mr0316-118rr world health organization	ORG
ajlm-1964	502	1	2021	CARDINAL
ajlm-1964	503	1	2021	CARDINAL
ajlm-1964	503	2	dec 25	DATE
ajlm-1964	504	1	sci monit	ORG
ajlm-1964	505	1	2021;27	CARDINAL
ajlm-1964	507	1	marciano s	PERSON
ajlm-1964	509	1	nat	ORG
ajlm-1964	510	1	2021;6:1188–1198	CARDINAL
ajlm-1964	511	1	ren sy	PERSON
ajlm-1964	511	2	wang wb	PERSON
ajlm-1964	511	3	gao rd	PERSON
ajlm-1964	511	4	zhou	PERSON
ajlm-1964	512	1	omicron	ORG
ajlm-1964	513	1	j clin	PERSON
ajlm-1964	514	1	2022;10(1):1–11	CARDINAL
ajlm-1964	517	1	hong kong	GPE
ajlm-1964	518	1	hku med.	ORG
ajlm-1964	518	2	e. omicron	PERSON
ajlm-1964	520	1	2021;600:367–368	CARDINAL
ajlm-1964	522	1	callaway e	PERSON
ajlm-1964	522	2	ledford h.	ORG
ajlm-1964	524	1	2021;600:197–199	CARDINAL
ajlm-1964	525	1	https://doi.org/10.1038/d41586-021-03614-z pfizer inc	ORG
ajlm-1964	527	1	2021	CARDINAL
ajlm-1964	528	1	2021	CARDINAL
ajlm-1964	528	2	dec 09	DATE
ajlm-1964	529	1	grikscheit k	PERSON
ajlm-1964	531	1	2021	CARDINAL
ajlm-1964	531	2	21267432	DATE
ajlm-1964	532	1	2021	CARDINAL
ajlm-1964	532	2	dec 09	DATE